Biotechnology Stocks I Performance Guide: Day One Biopharmaceuticals, Inc. (DAWN)
DAWN has no dividends
Table and Chart of DAWN Performance
See what a $1,000 investment in DAWN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| DAWN Returns | |
|---|---|
| Start Date | Jun-30-2021 |
| Start Price | $22.77 |
| End Date | Dec-01-2023 |
| End Price | $12.26 |
| # Prices | 31 |
| Min Date | May-31-2022 |
| Min Price | $6.22 |
| Max Date | Aug-31-2021 |
| Max Price | $27.83 |
| Total Return | -46.16% |
| Annualized Return | -21.31% |
| Current Value of $1,000 Purchase | $538 |
| Number Returns | 465 |
| Average Return | -5.77% |
| Number Profitable Returns | 136 |
| Percent Profitable Returns | 29.25% |
| Number Unprofitable Returns | 329 |
| Percent Unprofitable Returns | 70.75% |
| Profitable to Unprofitable Returns Ratio | 0.41 |
| DAWN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,069,763,000 | Price to Sales |
| Earnings per Share | $-2.2900 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.732 |
| PRICE DATA | |
| 52 Week High | $25.77 |
| 52 Week Low | $9.67 |
| Analyst Target Price | $37.78 |
| 50-Day Moving Average | $11.59 |
| 200-Day Moving Average | $13.4 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -0.464% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
DAWN Compare Returns with S&P 500
DAWN Trendline Chart